Related Research Articles
The Lemelson-MIT Program awards several prizes yearly to inventors in the United States. The largest is the Lemelson–MIT Prize which was endowed in 1994 by Jerome H. Lemelson, funded by the Lemelson Foundation, and is administered through the School of Engineering at the Massachusetts Institute of Technology. The winner receives $500,000, making it the largest cash prize for invention in the U.S.
Gertrude "Trudy"Belle Elion was an American biochemist and pharmacologist, who shared the 1988 Nobel Prize in Physiology or Medicine with George H. Hitchings and Sir James Black for their use of innovative methods of rational drug design for the development of new drugs. This new method focused on understanding the target of the drug rather than simply using trial-and-error. Her work led to the creation of the anti-retroviral drug AZT, which was the first drug widely used against AIDS. Her well known works also include the development of the first immunosuppressive drug, azathioprine, used to fight rejection in organ transplants, and the first successful antiviral drug, acyclovir (ACV), used in the treatment of herpes infection.
Raymond Allen Dwek CBE FRS FRSC is a scientist at the University of Oxford and co-founder of the biotechnology company Oxford GlycoSciences Ltd.,
The Rega Institute for Medical Research is a Belgian scientific establishment that is part of the Catholic University of Leuven (Leuven) in central Belgium. The Rega Institute is an interfacultary biomedical research institute of the Catholic University of Leuven and consists of departments of medicine and pharmacology.
Désiré, Baron Collen is a Belgian physician, chemist, biotechnology entrepreneur and life science investor. He made several discoveries in thrombosis, haemostasis and vascular biology in many of which serendipity played a significant role. His main achievement has been his role in the development of tissue-type plasminogen activator (t-PA) from a laboratory concept to a life-saving drug for dissolving blood clots causing acute myocardial infarction or acute ischemic stroke. Recombinant t-PA was produced and marketed by Genentech Inc as Activase and by Boehringer Ingelheim GmbH as Actilyse, and is considered biotechnology's first life saving drug.
Rudi Pauwels is a Belgian pharmacologist and biotech entrepreneur.
The Dr. Paul Janssen Award for Biomedical Research is given annually by Johnson & Johnson to honor the work of an active scientist in academia, industry or a scientific institute in the field of biomedical research. It was established in 2004 and perpetuates the memory of Paul Janssen, the founder of Janssen Pharmaceutica, a Johnson & Johnson subsidiary.
Charon Robin Ganellin FRS is a British medicinal chemist, and Emeritus Smith Kline and French Professor of Medicinal Chemistry, at University College London.
Antonín Holý was a pioneering Czech scientist. He specialised in the field of chemistry and cooperated on the development of important antiretroviral drugs used in the treatment of HIV and hepatitis B. He was involved in the creation of the most effective drug in the treatment of AIDS. Antonín Holý is the author of more than 450 papers, 400 scientific discoveries and holds 60 patents. With more than 400 discoveries to his credit, his work has affected millions of people with viral diseases such as HIV/AIDS and hepatitis B and many other viral diseases. In 2008 he received an Honorary Professorship at the University of Manchester's School of Chemistry.
Christofer "Chris" Toumazou, FRS, FREng, FMedSci, FIET, FIEEE, FCGI, FRSM, CEng is a British Cypriot electronic engineer.
William Herman Prusoff was a pharmacologist who was an early innovator in antiviral drugs, developing idoxuridine, the first antiviral agent approved by the FDA, in the 1950s, and co-developing stavudine, one of the earliest AIDS drugs, in the mid-1980s.
The European Inventor Award or European Inventor awards, are presented annually by the European Patent Office, sometimes supported by the respective Presidency of the Council of the European Union and by the European Commission, to inventors who have made a significant contribution to innovation, economy and society in Europe. Inventions from all technological fields are considered for this award. The winners in each category are presented with an award shaped like a sail. There is no cash prize associated with the award.
John Charles Martin was an American billionaire businessman, and the former executive chairman (2016–2018) and CEO (1996–2016) of the American biotechnology company Gilead Sciences. He joined Gilead Sciences in 1990 as vice president for research and development. Gilead is known for developing drugs such as Atripla and commercializing Sovaldi (sofosbuvir) for the treatment of the liver virus hepatitis C. Martin is the recipient of a number of awards, including the Biotechnology Heritage Award (2017).
Robert Vince is an American scientist known for his contributions to the research in the area of drug design. He is currently the director and professor at the Center for Drug Design at the Academic Health Center for the University of Minnesota.
Harkishan Singh was Professor Emeritus at the Panjab University. He was a well recognized pharmaceutical academic, medicinal chemistry researcher and science historian. He had more than half a century experience in his respective fields to his credit. He worked at the Banaras Hindu University, University of Saugar, and the Panjab University in India, and abroad at the University of Maryland, University of Mississippi and the University of London.
Professor Surendra Nath Pandeya was an Indian medicinal and organic chemist. He made several contributions in the design and discovery of anticonvulsant, antitubercular, anti-HIV, anti-cancer, antibacterial, and antimicrobial molecules. His research focused on semicarbazones, Mannich bases, thiadiazoles, benzothiazoles, and oxindole compounds.
Raymond F. Schinazi is an American organic medicinal chemist with expertise in antiviral agents, pharmacology, and biotechnology. His research focuses on developing treatments for infections caused by human immunodeficiency virus (HIV), hepatitis B (HBV), hepatitis C (HCV), herpes, dengue fever, zika, chikungunya, and other emerging viruses. These treatment options include antiviral agents as well as synthetic, biochemical, pharmacological and molecular genetic approaches, including molecular modeling and gene therapy.
Johan Hendrik Neyts is a Belgian virologist. He is head of The Neyts-lab of Virology, Antiviral Drug and Vaccine Research, which is part of the Laboratory of Virology and Chemotherapy at the Rega Institute for Medical Research, and full professor of virology at the Faculty of Medicine of KU Leuven. During the 2019-2020 coronavirus pandemic, Neyts came to national prominence as an expert on the (re)search for antiviral drugs and vaccines against SARS-CoV-2.
The International Society for Antiviral Research (ISAR) is a scientific society that focuses on the discovery and clinical application of antiviral agents. It was founded in 1987 to encourage the exchange of information and collaborative research on the development of antiviral, biological and chemical agents.
Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences is a research institute under the Czech Academy of Sciences (CAS). The institute centers around research in the fields of organic chemistry, biochemistry and neighboring disciplines, mostly oriented at applications in medicine and environment. It is known for its contribution in the development of key drugs against HIV and HBV. The institute also takes part in university education, supervising master's and doctoral theses.
References
- ↑ The International Society for Antiviral Research: The First Decade 1987-1997 (PDF). International Society for Antiviral Research. 1998.
- ↑ Colacino, Joseph M. (April 2013). "Professor De Clercq and 25 Years of International Collaboration on Antiviral Research". Antiviral Chemistry and Chemotherapy. 23 (2): 57–58. doi:10.3851/IMP2395 . Retrieved 11 May 2020.
- ↑ Vere Hodge, R. Anthony (2019). The International Society for Antiviral Research: The Third Decade 2008-2017 (PDF). International Society for Antiviral Research.
- ↑ European Inventor of the Year 2008 in the category "lifetime achievement"
| General | |
|---|---|
| National libraries | |
| Other | |
   | This article about a Belgian scientist is a stub. You can help Wikipedia by expanding it. |